GASTROINTESTINAL CANCERS
Clinical trials for GASTROINTESTINAL CANCERS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL CANCERS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Not yet recruitingThis study tests a new drug, BHB810, in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety, find the best dose, and see if it can s…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
New combo therapy for advanced cancers enters real-world trial
Disease control Not yet recruitingThis study will observe 300 people with advanced solid tumors (like lung or gastrointestinal cancers) who receive adebrelimab combined with other treatments. The goal is to see how safe and effective these combinations are in everyday medical practice. Researchers will track side…
Matched conditions: GASTROINTESTINAL CANCERS
Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
AI tool aims to speed up recovery after gut cancer surgery
Knowledge-focused Not yet recruitingThis study looks at whether an artificial intelligence (AI) tool can help doctors decide when it's safe for patients to start early rehabilitation after gastrointestinal or cancer surgery. The tool uses routine hospital data to give a simple yes or no answer. About 103 adults wil…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC
-
A randomized, double-blind, placebo-controlled, prospective, multi-center trial evaluating the improvement of nutritional status and sarcopenia with silkworm pupa tablets in patients with malignancies
Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel-group, prospective, multi-center clinical trial, to evaluate the efficacy of silkworm pupa tablets in improving nutritional status and sarcopenia in patients with malignancies who have completed comprehensive treatm…
Matched conditions: GASTROINTESTINAL CANCERS
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University
Last updated May 11, 2026 20:49 UTC